Medical specialists from Israel tagged as investigators in clinical trials studying Multiple Sclerosis
Total 24 results
-
Adi Nov-SharabiSeen in:
- Safed, Ziv Medical Center
Trials:- NCT01918501 (Sub-Investigator)
Conditions: -
Adi Vaknin-DembinskySeen in:
- Levant, Jerusalem, Hadassah University Hospital - Ein Kerem
Trials:- NCT03958877 (Principal Investigator)
Conditions: -
Adi Vaknine-Dembinsky, Dr.Seen in:
- Jerusalem, Hadassah Hebrew University
Trials:- NCT05605951 (Sub-Investigator)
-
Adi Wilf-Yarkoni, Dr.Seen in:
- Tel Aviv, Sackler School of Medicine and Rabin Medical Center
Trials:- NCT05605951 (Sub-Investigator)
-
Alon Tiosano, Dr.Seen in:
- Tel Aviv, Sackler School of Medicine and Rabin Medical Center
Trials:- NCT05605951 (Sub-Investigator)
-
Anat Achiron, MD PhDSeen in:
- Ramat Gan, Multiple Sclerosis Center
- Ramat Gan, Sheba Medical Center
- Ramat-gan, Multiple Sclerosis Center, Sheba Medical Center
Trials:- NCT00220493 (Principal Investigator)
- NCT00220428 (Principal Investigator)
- NCT00230204 (Principal Investigator)
- NCT05075499 (Principal Investigator)
-
Anda EilamSeen in:
- HaMerkaz, Rehovot, Kaplan Medical Center
Trials:- NCT06220669 (Principal Investigator)
Conditions: -
Ariel Miller, MD PhDSeen in:
- Haifa, Carmel Medical Center
- Haifa, MS Clinic, Carmel Medical Center
Trials:- NCT02488343 (Principal Investigator)
- NCT01954823 (Principal Investigator)
Conditions: -
Ayelet Omer-Armon, PHDSeen in:
- Safed, Ziv Medical Center
Trials:- NCT01918501 (Sub-Investigator)
Conditions: -
Dimitrios Karussis, Prof.Seen in:
- Jerusalem, Hadassah Medical Center
Trials:- NCT03486665 (Principal Investigator)
Conditions: -
Esther Ganelin-CohenSeen in:
- Tel Aviv, Petach-Tikva, Schneider Children's Medical Center
Trials:- NCT03958877 (Principal Investigator)
Conditions: -
Gad Lavie, DrSeen in:
- Ramat Gan, Sheba Medical Center
Trials:- NCT00228228 (Sub-Investigator)
Conditions: -
Hadas Stiebel-Kalish, Prof.Seen in:
- Tel Aviv, Sackler School of Medicine and Rabin Medical Center
Trials:- NCT05605951 (Principal Investigator)
-
Mark Dolev, MDSeen in:
- Tel Hashomer, Multiple Sclerosis Center
Trials:- NCT00220506 (Principal Investigator)
Conditions: -
Mark Hellmann, Dr.Seen in:
- Tel Aviv, Sackler School of Medicine and Rabin Medical Center
Trials:- NCT05605951 (Sub-Investigator)
-
Netta Levin, Prof.Seen in:
- Jerusalem, Hadassah Hebrew University
Trials:- NCT05605951 (Principal Investigator)
-
Omer Bialer, Dr.Seen in:
- Tel Aviv, Sackler School of Medicine and Rabin Medical Center
Trials:- NCT05605951 (Sub-Investigator)
-
Ron MiloSeen in:
- Ashkelon, Barzilai Medical Center
Trials:- NCT06220669 (Principal Investigator)
Conditions: -
Saad Abu Saleh, MDSeen in:
- Safed, Ziv Medical Center
Trials:- NCT01918501 (Sub-Investigator)
Conditions: -
Samih BadarnySeen in:
- HaZafon, Nahariya, Galilee Medical Center
Trials:- NCT06220669 (Principal Investigator)
Conditions: -
Shira Rozenblatt, Dr.Seen in:
- Tel Aviv, Sackler School of Medicine and Rabin Medical Center
Trials:- NCT05605951 (Sub-Investigator)
-
Uri givon, MDSeen in:
- Ramat Gan, Motion Laboratory, Sheba medical center
- Tel Hashomer, Multiple Sclerosis Center, Sheba Medical Center
Trials:- NCT00331747 (Principal Investigator)
- NCT01562418 (Principal Investigator)
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States